Literature DB >> 20719554

Acute homocysteine rise after repeated levodopa application in patients with Parkinson's disease.

Thomas Müller, Siegfried Muhlack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20719554     DOI： 10.1016/j.parkreldis.2010.07.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  4 in total

1.  Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.

Authors:  Thomas Müller; Constanze Jugel; Reinhard Ehret; Georg Ebersbach; Gunar Bengel; Siegfried Muhlack; Fabian Klostermann
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

2.  Inhibition of catechol-O-methyltransferase modifies acute homocysteine rise during repeated levodopa application in patients with Parkinson's disease.

Authors:  Thomas Müller; Dirk Woitalla; Siegfried Muhlack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

3.  Effects of One-Day Application of Levodopa/Carbidopa/Entacapone versus Levodopa/Carbidopa/Opicapone in Parkinson's Disease Patients.

Authors:  Thomas Müller; Eugen Schlegel; Stephanie Zingler; Hans Michael Thiede
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

4.  Urate and Homocysteine: Predicting Motor and Cognitive Changes in Newly Diagnosed Parkinson's Disease.

Authors:  Isobel Sleeman; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Fionnuala Johnston; Tien K Khoo; David J Burn
Journal:  J Parkinsons Dis       Date:  2019       Impact factor: 5.520
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.